# Atlassian Corp: financial statements, quarterly

TEAM · Nasdaq · CIK 1650372 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/team.md) · [Financials](/companies/team/financials.md) · [Filings](/companies/team/filings.md) · [Insiders](/companies/team/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/team/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [978](/filings/0001650372-24-000056.md) | [1,060](/filings/0001650372-25-000009.md) | [1,189](/filings/0001650372-25-000022.md) | [1,132 d](/filings/0001650372-26-000036.md) | [1,188](/filings/0001650372-25-000068.md) | [1,286](/filings/0001650372-26-000011.md) | [1,357](/filings/0001650372-26-000027.md) | [1,384 d](/filings/0001650372-26-000036.md) | [1,433](/filings/0001650372-25-000068.md) | [1,586](/filings/0001650372-26-000011.md) | [1,787](/filings/0001650372-26-000027.md) | [1,766 d](/filings/0001650372-26-000036.md) |
| Cost of revenue | $m | [178](/filings/0001650372-23-000060.md) | [195](/filings/0001650372-24-000010.md) | [213](/filings/0001650372-25-000022.md) | [218 d](/filings/0001650372-24-000036.md) | [218](/filings/0001650372-25-000068.md) | [223](/filings/0001650372-26-000011.md) | [220](/filings/0001650372-26-000027.md) | [234 d](/filings/0001650372-26-000036.md) | [258](/filings/0001650372-25-000068.md) | [238](/filings/0001650372-26-000011.md) | [263](/filings/0001650372-26-000027.md) | [238 d](/filings/0001650372-26-000036.md) |
| Gross profit | $m | [800](/filings/0001650372-24-000056.md) | [866](/filings/0001650372-25-000009.md) | [976](/filings/0001650372-25-000022.md) | [914 d](/filings/0001650372-26-000036.md) | [970](/filings/0001650372-25-000068.md) | [1,063](/filings/0001650372-26-000011.md) | [1,137](/filings/0001650372-26-000027.md) | [1,150 d](/filings/0001650372-26-000036.md) | [1,175](/filings/0001650372-25-000068.md) | [1,349](/filings/0001650372-26-000011.md) | [1,524](/filings/0001650372-26-000027.md) | [1,528 d](/filings/0001650372-26-000036.md) |
| Research and development | $m | [482](/filings/0001650372-24-000056.md) | [537](/filings/0001650372-25-000009.md) | [576](/filings/0001650372-25-000022.md) | [589 d](/filings/0001650372-26-000036.md) | [603](/filings/0001650372-25-000068.md) | [680](/filings/0001650372-26-000011.md) | [685](/filings/0001650372-26-000027.md) | [701 d](/filings/0001650372-26-000036.md) | [756](/filings/0001650372-25-000068.md) | [826](/filings/0001650372-26-000011.md) | [927](/filings/0001650372-26-000027.md) | [760 d](/filings/0001650372-26-000036.md) |
| Operating income | $m | [(18.9)](/filings/0001650372-24-000056.md) | [(49.1)](/filings/0001650372-25-000009.md) | [17.8](/filings/0001650372-25-000022.md) | [(67.0) d](/filings/0001650372-26-000036.md) | [(32.0)](/filings/0001650372-25-000068.md) | [(57.5)](/filings/0001650372-26-000011.md) | [(12.5)](/filings/0001650372-26-000027.md) | [(28.5) d](/filings/0001650372-26-000036.md) | [(96.3)](/filings/0001650372-25-000068.md) | [(47.7)](/filings/0001650372-26-000011.md) | [(56.3)](/filings/0001650372-26-000027.md) | [211 d](/filings/0001650372-26-000036.md) |
| Interest expense | $m | [9.0](/filings/0001650372-24-000056.md) | [9.0](/filings/0001650372-24-000010.md) | [8.5](/filings/0001650372-24-000016.md) | [7.6 d](/filings/0001650372-26-000036.md) | [7.3](/filings/0001650372-24-000056.md) | [7.3](/filings/0001650372-26-000011.md) | [7.8](/filings/0001650372-26-000027.md) | [8.1 d](/filings/0001650372-26-000036.md) | [8.6](/filings/0001650372-25-000068.md) | [12.5](/filings/0001650372-26-000011.md) | [14.1](/filings/0001650372-26-000027.md) | [14.1 d](/filings/0001650372-26-000036.md) |
| Income tax | $m | [20.9](/filings/0001650372-24-000056.md) | [44.4](/filings/0001650372-25-000009.md) | [7.0](/filings/0001650372-25-000022.md) | [143 d](/filings/0001650372-26-000036.md) | [93.6](/filings/0001650372-25-000068.md) | [(9.0)](/filings/0001650372-26-000011.md) | [63.5](/filings/0001650372-26-000027.md) | [9.7 d](/filings/0001650372-26-000036.md) | [(4.5)](/filings/0001650372-25-000068.md) | [(13.1)](/filings/0001650372-26-000011.md) | [35.6](/filings/0001650372-26-000027.md) | [57.8 d](/filings/0001650372-26-000036.md) |
| Net income | $m | [(31.9)](/filings/0001650372-24-000056.md) | [(84.5)](/filings/0001650372-25-000009.md) | [12.8](/filings/0001650372-25-000022.md) | [(197) d](/filings/0001650372-26-000036.md) | [(124)](/filings/0001650372-25-000068.md) | [(38.2)](/filings/0001650372-26-000011.md) | [(70.8)](/filings/0001650372-26-000027.md) | [(23.9) d](/filings/0001650372-26-000036.md) | [(51.9)](/filings/0001650372-25-000068.md) | [(42.6)](/filings/0001650372-26-000011.md) | [(98.4)](/filings/0001650372-26-000027.md) | [139 d](/filings/0001650372-26-000036.md) |
| Diluted EPS | $ per share | [(0.12)](/filings/0001650372-24-000056.md) | [(0.33)](/filings/0001650372-25-000009.md) | [0.05](/filings/0001650372-25-000022.md) | not reported | [(0.48)](/filings/0001650372-25-000068.md) | [(0.15)](/filings/0001650372-26-000011.md) | [(0.27)](/filings/0001650372-26-000027.md) | not reported | [(0.20)](/filings/0001650372-25-000068.md) | [(0.16)](/filings/0001650372-26-000011.md) | [(0.38)](/filings/0001650372-26-000027.md) | not reported |
| Basic EPS | $ per share | [(0.12)](/filings/0001650372-24-000056.md) | [(0.33)](/filings/0001650372-25-000009.md) | [0.05](/filings/0001650372-25-000022.md) | not reported | [(0.48)](/filings/0001650372-25-000068.md) | [(0.15)](/filings/0001650372-26-000011.md) | [(0.27)](/filings/0001650372-26-000027.md) | not reported | [(0.20)](/filings/0001650372-25-000068.md) | [(0.16)](/filings/0001650372-26-000011.md) | [(0.38)](/filings/0001650372-26-000027.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2,144](/filings/0001650372-24-000056.md) | [1,460](/filings/0001650372-25-000009.md) | [1,949](/filings/0001650372-25-000022.md) | [2,177](/filings/0001650372-26-000036.md) | [2,056](/filings/0001650372-25-000068.md) | [2,218](/filings/0001650372-26-000011.md) | [2,661](/filings/0001650372-26-000027.md) | [2,513](/filings/0001650372-26-000036.md) | [2,322](/filings/0001650372-25-000068.md) | [1,158](/filings/0001650372-26-000011.md) | [1,136](/filings/0001650372-26-000027.md) | [1,240](/filings/0001650372-26-000036.md) |
| Current assets | $m | [2,736](/filings/0001650372-23-000060.md) | [2,272](/filings/0001650372-24-000010.md) | [2,914](/filings/0001650372-24-000016.md) | [3,076](/filings/0001650372-25-000036.md) | [2,867](/filings/0001650372-24-000056.md) | [3,322](/filings/0001650372-25-000009.md) | [3,775](/filings/0001650372-25-000022.md) | [3,891](/filings/0001650372-26-000036.md) | [3,627](/filings/0001650372-25-000068.md) | [2,775](/filings/0001650372-26-000011.md) | [2,334](/filings/0001650372-26-000027.md) | [2,797](/filings/0001650372-26-000036.md) |
| Total assets | $m | [4,080](/filings/0001650372-23-000060.md) | [4,449](/filings/0001650372-24-000010.md) | [5,063](/filings/0001650372-24-000016.md) | [5,212](/filings/0001650372-25-000036.md) | [4,993](/filings/0001650372-24-000056.md) | [5,446](/filings/0001650372-25-000009.md) | [5,884](/filings/0001650372-25-000022.md) | [6,042](/filings/0001650372-26-000036.md) | [5,721](/filings/0001650372-25-000068.md) | [6,160](/filings/0001650372-26-000011.md) | [5,651](/filings/0001650372-26-000027.md) | [6,104](/filings/0001650372-26-000036.md) |
| Current liabilities | $m | [1,907](/filings/0001650372-23-000060.md) | [2,118](/filings/0001650372-24-000010.md) | [2,468](/filings/0001650372-24-000016.md) | [2,610](/filings/0001650372-25-000036.md) | [2,436](/filings/0001650372-24-000056.md) | [2,685](/filings/0001650372-25-000009.md) | [2,991](/filings/0001650372-25-000022.md) | [3,181](/filings/0001650372-26-000036.md) | [2,871](/filings/0001650372-25-000068.md) | [3,117](/filings/0001650372-26-000011.md) | [3,323](/filings/0001650372-26-000027.md) | [3,571](/filings/0001650372-26-000036.md) |
| Total liabilities | $m | [3,305](/filings/0001650372-23-000060.md) | [3,545](/filings/0001650372-24-000010.md) | [3,929](/filings/0001650372-24-000016.md) | [4,179](/filings/0001650372-25-000036.md) | [3,964](/filings/0001650372-24-000056.md) | [4,227](/filings/0001650372-25-000009.md) | [4,515](/filings/0001650372-25-000022.md) | [4,696](/filings/0001650372-26-000036.md) | [4,342](/filings/0001650372-25-000068.md) | [4,570](/filings/0001650372-26-000011.md) | [4,772](/filings/0001650372-26-000027.md) | [5,045](/filings/0001650372-26-000036.md) |
| Long-term debt | $m | [950](/filings/0001650372-23-000060.md) | [937](/filings/0001650372-24-000010.md) | [925](/filings/0001650372-24-000016.md) | [986](/filings/0001650372-25-000036.md) | [986](/filings/0001650372-24-000056.md) | [987](/filings/0001650372-25-000009.md) | [987](/filings/0001650372-25-000022.md) | [988](/filings/0001650372-26-000036.md) | [988](/filings/0001650372-25-000068.md) | [989](/filings/0001650372-26-000011.md) | [989](/filings/0001650372-26-000027.md) | [990](/filings/0001650372-26-000036.md) |
| Current portion of debt | $m | [50.0](/filings/0001650372-23-000060.md) | [50.0](/filings/0001650372-24-000010.md) | [50.0](/filings/0001650372-24-000016.md) | [0.0](/filings/0001650372-24-000036.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [775](/filings/0001650372-25-000009.md) | [905](/filings/0001650372-25-000022.md) | [1,134](/filings/0001650372-25-000022.md) | [1,033](/filings/0001650372-26-000036.md) | [1,029](/filings/0001650372-26-000011.md) | [1,220](/filings/0001650372-26-000027.md) | [1,369](/filings/0001650372-26-000027.md) | [1,346](/filings/0001650372-26-000036.md) | [1,379](/filings/0001650372-26-000011.md) | [1,591](/filings/0001650372-26-000027.md) | [879](/filings/0001650372-26-000027.md) | [1,058](/filings/0001650372-26-000036.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [167](/filings/0001650372-24-000056.md) | [290](/filings/0001650372-25-000009.md) | [565](/filings/0001650372-25-000022.md) | [426 d](/filings/0001650372-26-000036.md) | [80.5](/filings/0001650372-25-000068.md) | [352](/filings/0001650372-26-000011.md) | [653](/filings/0001650372-26-000027.md) | [375 d](/filings/0001650372-26-000036.md) | [129](/filings/0001650372-25-000068.md) | [178](/filings/0001650372-26-000011.md) | [567](/filings/0001650372-26-000027.md) | [479 d](/filings/0001650372-26-000036.md) |
| Capital expenditure | $m | [3.7](/filings/0001650372-24-000056.md) | [5.3](/filings/0001650372-25-000009.md) | [10.5](/filings/0001650372-25-000022.md) | [13.6 d](/filings/0001650372-26-000036.md) | [6.2](/filings/0001650372-25-000068.md) | [9.3](/filings/0001650372-26-000011.md) | [14.4](/filings/0001650372-26-000027.md) | [15.0 d](/filings/0001650372-26-000036.md) | [14.1](/filings/0001650372-25-000068.md) | [9.3](/filings/0001650372-26-000011.md) | [6.2](/filings/0001650372-26-000027.md) | [4.4 d](/filings/0001650372-26-000036.md) |
| Share repurchases | $m | [65.9](/filings/0001650372-24-000056.md) | [102](/filings/0001650372-25-000009.md) | [35.4](/filings/0001650372-25-000022.md) | [192 d](/filings/0001650372-26-000036.md) | [184](/filings/0001650372-25-000068.md) | [69.2](/filings/0001650372-26-000011.md) | [134](/filings/0001650372-26-000027.md) | [392 d](/filings/0001650372-26-000036.md) | [253](/filings/0001650372-25-000068.md) | [197](/filings/0001650372-26-000011.md) | [991](/filings/0001650372-26-000027.md) | [359 d](/filings/0001650372-26-000036.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [255](/filings/0001650372-23-000060.md) | [256](/filings/0001650372-24-000010.md) | [257](/filings/0001650372-24-000016.md) | [258](/filings/0001650372-24-000056.md) | [259](/filings/0001650372-25-000009.md) | [262](/filings/0001650372-25-000022.md) | [260](/filings/0001650372-25-000068.md) | [261](/filings/0001650372-26-000011.md) | [263](/filings/0001650372-26-000027.md) | [263](/filings/0001650372-25-000068.md) | [264](/filings/0001650372-26-000011.md) | [261](/filings/0001650372-26-000027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.